Company Filing History:
Years Active: 2021
Title: **Mirian Velasco: Innovator in Ophthalmic Lens Technology**
Introduction
Mirian Velasco, an accomplished inventor based in Madrid, Spain, has made significant contributions to the field of ophthalmic technology. With a specialization in developing methods to enhance visual acuity, she holds a patent that addresses unwanted astigmatism in ophthalmic lenses, benefiting wearers worldwide.
Latest Patents
Mirian Velasco's notable patent, titled "Method for determining an ophthalmic lens having unwanted astigmatism," describes a sophisticated technique to create personalized lenses. This method incorporates specific data from the wearer, including prescription information and focal preferences, to optimize the optic performance of the lens and minimize unwanted astigmatism effects. This innovation can substantially improve the visual comfort and clarity for individuals requiring corrective lenses.
Career Highlights
Velasco is currently employed at Essilor International, a renowned company recognized for its leadership in optical health and premium eyewear solutions. Her role within this innovative organization allows her to apply her expertise in developing cutting-edge ophthalmic technologies that cater to a diverse range of vision correction needs.
Collaborations
Throughout her career, Mirian has collaborated with distinguished professionals in her field, including Susana Marcos and Carlos Dorronsoro. These collaborations have fostered an environment of shared knowledge and innovation, further enhancing the impact of her work in ophthalmic research and development.
Conclusion
Mirian Velasco stands as a prominent figure in the realm of ophthalmic lens innovation. Her commitment to improving vision through personalized lens design is reflected in her patent and the collaborative efforts with esteemed professionals. As she continues to advance in her career, her contributions are sure to lead to further advancements in optical technology, benefitting millions of eyewear users globally.